Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration...

October 18, 2019 | Friday | News
Lilly's Migraine drug receives FDA approval

Eli Lilly and Company  has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW...

October 14, 2019 | Monday | News
Gilead Sciences submits NDA to treat RA in Japan

Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, select...

October 9, 2019 | Wednesday | News
Bayer and RIKEN establish partnership for novel drug discovery

Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreeme...

October 9, 2019 | Wednesday | News
Novo Nordisk set to bring innovative treatment for type 2 diabetes

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) ta...

September 23, 2019 | Monday | News
FDA approves combo drug to treat endometrial carcinoma

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the...

September 19, 2019 | Thursday | News
FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab)

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakt...

September 18, 2019 | Wednesday | News
FDA grants priority review for Merck’s Ebola Vaccine

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA)...

September 17, 2019 | Tuesday | Influencers
Certara launches V8.2 of Phoenix PK/PD modeling & simulation software for drugs

Certara®, the global model-informed drug development and decision support leader, on 12 Sep 2019, announced the laun...

September 15, 2019 | Sunday | News
Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...

September 12, 2019 | Thursday | News
Hansoh Pharma, Atomwise partner for AI Drug Discovery

Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China,...

September 12, 2019 | Thursday | News
Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan

 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...

September 10, 2019 | Tuesday | News
Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan

Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and s...

August 30, 2019 | Friday | News
THC Global Groups' Australalia's Facility Opened by Federal Minister for Health

THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal...

August 22, 2019 | Thursday | News
FDA fast tracks AstraZeneca's FARXIGA

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the deve...

August 28, 2019 | Wednesday | News
Japan's BioWa extends partnership with Cantargia

Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTe...

August 27, 2019 | Tuesday | News
Voronoi selects CDD Vault platform to manage Drug Discovery Data

Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluatio...

August 23, 2019 | Friday | News
Innovent to develop & commercialize a novel diabetes medicine in China

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicine...

August 22, 2019 | Thursday | News